[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2017/6281,2017,A1Locationinpatent:Page/Pagecolumn71-72
1217501-01-3
1217500-97-4
1217501-02-4
1217500-92-9
279261-73-3
820972-68-7
1218-40-2 | 1H-Indole-3-ethanamine, N,N-diethyl-5-methoxy- | AA0015ZD
1218790-82-9 | 3-(4-(BOC-Piperazine-1-carbonyl)phenylboronic acid | AA00167J | MFCD12546575
1219956-30-5 | 9-Phenyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-9h-carbazole | AA0016FU | MFCD30187279
1221288-27-2 | Methyl 3-bromo-1h-pyrazolo[3,4-b]pyridine-5-carboxylate | AA0016QB | MFCD17016018
122323-88-0 | Piperazine-2-carboxylic acid methyl ester DiHCl | AA00170Y | MFCD01861815
1225608-24-1 | Potassium benzofurazan-5-trifluoroborate | AA0017DQ | MFCD09800741
1380006-72-3 | ((1R,8S,9R)-Bicyclo[6.1.0]non-4-yn-9-yl)methyl 4-nitrophenyl carbonate | AA0017QQ | MFCD31734691
1381944-41-7 | 3-[3-(Benzyloxy)phenyl]-2-fluorobenzoic acid | AA00184B | MFCD22375079
1383813-54-4 | (1R,3R)-3-(Benzyloxy)cyclobutan-1-ol | AA0018ME | MFCD22397416
138495-42-8 | Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro- | AA001983 | MFCD00798129